Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
William G WierdaJohn C ByrdSusan O'BrienSteven CoutrePaul M BarrRichard R FurmanThomas J KippsJan A BurgerDon A StevensJeff SharmanPaolo GhiaIan W FlinnCathy ZhouJoi NinomotoDanelle F JamesConstantine S TamPublished in: British journal of haematology (2019)